Gambaran Umum
SCYNEXIS, Inc., based in the United States, operates within the biotechnology industry, focusing on the development and commercialization of innovative therapies to address unmet medical needs. The company's key project is its flagship product, ibrexafungerp, a novel antifungal agent from a new class of structurally distinct glucan synthase inhibitors, designed to treat a variety of fungal infections including candidiasis and invasive aspergillosis. Ibrexafungerp is noteworthy for its oral and intravenous formulations, aiming to provide significant advantages over existing antifungal therapies. SCYNEXIS's strategic initiatives involve advancing this compound through clinical trials, securing regulatory approvals, and exploring its potential across multiple infectious disease indications to meet pressing healthcare challenges.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah 3.26 MM.
- Nilai operating income untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah -36.56 MM.
- Nilai net income untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah -19.52 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 3.26 | -36.56 | -19.52 |
2025-03-31 | 2.63 | -36.22 | -27.09 |
2024-12-31 | 3.75 | -37.12 | -21.29 |
2024-09-30 | 8.57 | -52.93 | -36.44 |
2024-06-30 | 9.67 | -51.91 | -35.39 |
2024-03-31 | 140.38 | 73.84 | 101.33 |
2023-12-31 | 140.14 | 72.67 | 67.04 |
2023-09-30 | 135.87 | 74.05 | 72.20 |
2023-06-30 | 135.66 | 61.55 | 44.37 |
2023-03-31 | 5.53 | -76.70 | -91.23 |
2022-12-31 | 5.09 | -85.76 | -62.81 |
2022-09-30 | 4.16 | -85.57 | -77.62 |
2022-06-30 | 3.12 | -83.21 | -48.64 |
2022-03-31 | 1.80 | -78.98 | -33.64 |
2021-12-31 | 13.16 | -60.84 | -32.87 |
2021-09-30 | 12.57 | -53.88 | -46.33 |
2021-06-30 | 12.05 | -45.95 | -44.82 |
2021-03-31 | 12.05 | -40.26 | -52.86 |
2020-12-31 | -51.15 | -55.19 | |
2020-09-30 | 0.00 | -49.92 | -26.93 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.56 | -0.56 |
2024-12-31 | -0.44 | -0.44 |
2024-09-30 | -0.75 | -0.78 |
2024-06-30 | -0.74 | -0.75 |
2024-03-31 | 2.11 | 2.09 |
2023-12-31 | 1.40 | 1.39 |
2023-09-30 | 1.51 | 1.51 |
2023-06-30 | 0.93 | 0.94 |
2023-03-31 | -1.96 | -1.94 |
2022-12-31 | -1.47 | -1.47 |
2022-09-30 | -2.07 | -1.65 |
2022-06-30 | -1.51 | -1.24 |
2022-03-31 | -1.20 | -1.18 |
2021-12-31 | -1.25 | -1.25 |
2021-09-30 | -2.04 | -2.60 |
2021-06-30 | -2.39 | -2.86 |
2021-03-31 | -3.59 | -3.68 |
2020-12-31 | -5.15 | |
2020-09-30 | -2.91 | -3.23 |
2020-06-30 | -4.48 | -4.48 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah -24.10 MM.
- Nilai cash from investing activities untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah 23.04 MM.
- Nilai kas dari aktivitas pendanaan untuk SCYNEXIS, Inc. per 2025 Jun 30 adalah -14.21 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -24.10 | 23.04 | -14.21 |
2025-03-31 | -27.47 | 13.14 | -14.21 |
2024-12-31 | -24.01 | 6.15 | -0.14 |
2024-09-30 | -21.84 | 6.62 | -0.12 |
2024-06-30 | -10.18 | -21.67 | -0.12 |
2024-03-31 | 75.08 | -29.42 | -36.76 |
2023-12-31 | 60.16 | -34.88 | -36.72 |
2023-09-30 | 45.09 | -32.73 | -36.59 |
2023-06-30 | 10.16 | -33.76 | -36.80 |
2023-03-31 | -82.82 | -27.38 | 41.90 |
2022-12-31 | -79.88 | -27.39 | 48.60 |
2022-09-30 | -82.60 | -27.97 | 79.08 |
2022-06-30 | -76.67 | -0.93 | 83.80 |
2022-03-31 | -69.79 | -0.98 | 73.91 |
2021-12-31 | -54.56 | -1.17 | 67.12 |
2021-09-30 | -45.61 | -0.59 | 116.76 |
2021-06-30 | -38.90 | 3.32 | 114.00 |
2021-03-31 | -36.06 | 14.04 | 93.78 |
2020-12-31 | -49.35 | 6.47 | 94.00 |
2020-09-30 | -46.24 | 16.52 | 47.60 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah 0.51.
- p/tbv untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah 0.51.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 0.51 | 0.51 | |
2025-03-31 | 0.71 | 0.71 | |
2024-12-31 | 0.69 | 0.69 | |
2024-09-30 | -1.64 | 0.96 | 0.96 |
2024-06-30 | 0.76 | 1.03 | 1.03 |
2024-03-31 | 0.58 | 0.58 | |
2023-12-31 | 1.15 | 0.90 | 0.90 |
2023-09-30 | 1.91 | 0.91 | 0.91 |
2023-06-30 | -1.21 | -3.69 | -3.65 |
2023-03-31 | -1.55 | 30.20 | |
2022-12-31 | 2.94 | 3.08 | |
2022-09-30 | 1.73 | 1.76 | |
2022-06-30 | -1.79 | 1.55 | 1.59 |
2022-03-31 | -3.38 | 2.69 | 2.69 |
2021-12-31 | -3.75 | 4.63 | 4.77 |
2021-09-30 | -2.74 | 3.79 | 3.86 |
2021-06-30 | |||
2021-03-31 | -1.04 | 2.12 | 2.16 |
2020-12-31 | -0.95 | 2.31 | 2.31 |
2020-09-30 | -1.07 | 3.02 | 3.02 |
2020-06-30 | -0.78 | 4.42 | 4.42 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.85.
- EBIT (3 tahun) / EV untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.18.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.85 | -0.18 |
2025-03-31 | -0.42 | -0.07 |
2024-12-31 | -1.44 | -0.48 |
2024-09-30 | -0.78 | -0.33 |
2024-06-30 | 1.55 | -0.16 |
2024-03-31 | 3.27 | -0.59 |
2023-12-31 | 1.43 | -0.39 |
2023-09-30 | 1.17 | -0.50 |
2023-06-30 | -0.71 | -0.50 |
2023-03-31 | -0.69 | -0.57 |
2022-12-31 | -3.05 | -2.00 |
2022-09-30 | -11.23 | -9.31 |
2022-06-30 | -4.43 | -4.49 |
2022-03-31 | -0.77 | -0.92 |
2021-12-31 | -0.44 | -0.48 |
2021-09-30 | -0.99 | -0.84 |
2021-06-30 | ||
2021-03-31 | 2.01 | 1.60 |
2020-12-31 | 2.18 | 1.64 |
2020-09-30 | -3.01 | -3.20 |
2020-06-30 | -4.09 | -3.69 |
Efektivitas Manajemen
- roa untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.25.
- roe untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.45.
- roic untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.41.
- croic untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.43.
- ocroic untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -0.41.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.25 | -0.45 | -0.41 | -0.43 | -0.41 |
2025-03-31 | -0.18 | -0.29 | -0.25 | -0.21 | -0.28 |
2024-12-31 | -0.28 | -0.50 | -0.49 | -0.21 | -0.29 |
2024-09-30 | -0.24 | -0.38 | -0.47 | -0.42 | -0.13 |
2024-06-30 | 1.44 | 1.00 | 0.09 | 0.74 | |
2024-03-31 | 0.82 | 22.33 | 0.68 | -0.23 | 0.42 |
2023-12-31 | 0.64 | 4.20 | 0.68 | -0.23 | 0.42 |
2023-09-30 | 0.33 | 0.98 | 0.41 | -0.56 | 0.09 |
2023-06-30 | -0.67 | -2.01 | 0.31 | -0.43 | 0.07 |
2023-03-31 | -0.56 | -1.61 | -4.90 | -3.67 | -4.45 |
2022-12-31 | -0.71 | -2.06 | -1.19 | -0.48 | -1.26 |
2022-09-30 | -0.44 | -1.29 | -1.19 | -0.48 | -1.27 |
2022-06-30 | -0.28 | -1.04 | -0.52 | 0.07 | -0.82 |
2022-03-31 | -0.33 | -1.27 | -0.41 | 0.04 | -0.85 |
2021-12-31 | -0.45 | -2.04 | -0.39 | 0.14 | -0.57 |
2021-09-30 | -1.22 | -4.69 | -0.59 | 0.89 | -0.53 |
2021-06-30 | -0.99 | -7.08 | -0.61 | 1.06 | -0.53 |
2021-03-31 | -1.27 | -8.19 | -1.36 | 1.85 | -0.93 |
2020-12-31 | -0.97 | -4.28 | -1.38 | 1.28 | -1.24 |
2020-09-30 | -0.80 | -4.38 | -1.14 | 0.76 | -1.96 |
2020-06-30 | -0.87 | -3.44 | -1.42 | 0.59 | -1.85 |
Gross Margins
- marjin kotor untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah 1.00.
- marjin bersih untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -10.30.
- marjin operasi untuk SCYNEXIS, Inc. pada 2025 Jun 30 adalah -13.77.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 1.00 | -10.30 | -13.77 |
2025-03-31 | -2.92 | -5.68 | -9.91 |
2024-12-31 | -0.71 | -4.25 | -6.18 |
2024-09-30 | -0.56 | -3.66 | -5.37 |
2024-06-30 | 0.89 | 0.72 | 0.53 |
2024-03-31 | 0.99 | 0.48 | 0.52 |
2023-12-31 | 0.99 | 0.53 | 0.54 |
2023-09-30 | 0.99 | 0.33 | 0.45 |
2023-06-30 | 0.88 | 0.33 | 0.45 |
2023-03-31 | 0.88 | -16.49 | -13.86 |
2022-12-31 | 0.86 | -18.64 | -20.55 |
2022-09-30 | 0.82 | -18.64 | -20.55 |
2022-06-30 | 0.77 | -15.58 | -26.64 |
2022-03-31 | 0.98 | -18.69 | -43.88 |
2021-12-31 | 0.99 | -2.50 | -4.62 |
2021-09-30 | 1.00 | -3.69 | -4.29 |
2021-06-30 | 1.00 | -3.72 | -3.81 |
2021-03-31 | 1.00 | -4.39 | -3.34 |
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1178253 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |